Come up with a name for your new list and we'll add to it:
Progenity raised a round of funding on August 16, 2016. Investors include
Athyrium Capital Management.
Progenity, formerly Ascendant MDX, is a biotechnology company with a presence in Women's Health molecular testing and a pipeline of proprietary tests and therapeutic applications under development. Pr…